These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 23762986)
21. [MORPHOLOGICAL CHANGES IN RAT MYOCARDIUM EXPOSED TO HEMIC HYPOXIA AND TREATED WITH CYTOFLAVIN.]. Zadnipryanyi IV; Tret'yakova OS; Sataeva TP Eksp Klin Farmakol; 2016 Aug; 79(5):20-25. PubMed ID: 29782775 [TBL] [Abstract][Full Text] [Related]
22. Evaluation of the Protective Effect of Ademetionine, Cytoflavin, and Dihydroquercetetine on Blood Enzymes Activity in Rats Treated with High Doses of Sodium Valproate. Okhremchuk LV; Seminskii IZ; Darenskaya MA; Grebenkina LA; Kolesnikova LI; Kolesnikov SI Bull Exp Biol Med; 2020 Dec; 170(2):211-214. PubMed ID: 33263851 [TBL] [Abstract][Full Text] [Related]
23. [Substantiation of the drug «Cytoflavin» application and cognitive-behavioral therapy in complex treatment of deforming coxarthrosis in elderly patients.]. Zakharov IK; Belov VG; Parfyonov UA; Parfyonov SA; Ershov EV; Sapozhnikov KV; Zaplutanov VA Adv Gerontol; 2019; 32(3):439-444. PubMed ID: 31512432 [TBL] [Abstract][Full Text] [Related]
24. [Effect of cytoflavine on bioenergetic processes in the liver after severe limb compression trauma]. Iunusov IA; Zarubina IV Eksp Klin Farmakol; 2009; 72(6):42-5. PubMed ID: 20095400 [TBL] [Abstract][Full Text] [Related]
25. [Free-radical oxidation in liver during experimental widespread purulent peritonitis]. Kosinets VA; Iarotskaia NN Eksp Klin Farmakol; 2012; 75(10):37-41. PubMed ID: 23240157 [TBL] [Abstract][Full Text] [Related]
26. [Dynamics of indicators of the functional state of the central nervous system in Navy operators treated with cytoflavin after a long working cycle]. Parfenov SA; Belov VG; Parfenov YA Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(8):55-58. PubMed ID: 28884718 [TBL] [Abstract][Full Text] [Related]
28. [The influence of Cytoflavin therapy on the cerebral hemodynamics in patients with various stages of hypertensive disease]. Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV; Scuderi A; Antignani PL Zh Nevrol Psikhiatr Im S S Korsakova; 2017; 117(7):28-35. PubMed ID: 28805757 [TBL] [Abstract][Full Text] [Related]
29. [Influence of multimodal effect of cytoflavin in the acute brain stroke in patients with metabolic syndrome]. Muratov FK; Shermukhamedova FK; Batocyrenov BV; Haritonova TV Zh Nevrol Psikhiatr Im S S Korsakova; 2016; 116(12):44-47. PubMed ID: 28139625 [TBL] [Abstract][Full Text] [Related]
30. [The use of cytoflavin for the treatment of chronic brucellosis]. Shul'diakov AA; Liapina EP; Soboleva LA; Reshetnikov AA; Zubareva EV; Trubetskov AD; Anashchenko AV; Evdokimov AV Klin Med (Mosk); 2011; 89(2):56-8. PubMed ID: 21574446 [TBL] [Abstract][Full Text] [Related]
31. [Effect of cytoflavin on the clinical and autonomic-psychological manifestations of hypertensive disease]. Belova LA; Mashin VV; Kolotik-Kameneva OY; Belova NV Ter Arkh; 2016; 88(5):55-61. PubMed ID: 27239928 [TBL] [Abstract][Full Text] [Related]
32. [Effect of cytoflavin on some physiological values in patients with toxicohypoxic encephalopathy]. Livanov GA; Lodiagin AN; Andrianov AIu; Batotsyrenov BV; Nikolaeva IP Eksp Klin Farmakol; 2013; 76(11):40-3. PubMed ID: 24555233 [TBL] [Abstract][Full Text] [Related]
33. [Protective effect of 3-oxypyridine and succinic acid derivatives under conditions of acute alloxan-induced intoxication in mice]. Volchegorskiĭ IA; Miroshnichenko IIu; Rassokhina LM; Malkin MP; Maĭzyllin RM; Priakhina KE; Kalugina AV Eksp Klin Farmakol; 2014; 77(1):13-6. PubMed ID: 24649596 [TBL] [Abstract][Full Text] [Related]
34. [Energy corrective and antioxidative actions of cytoflavin during postischemic period of human dermal fibroblasts in vitro]. Tiuriaeva II; Kuranova ML; Gonchar IV; Rozanov IuM Tsitologiia; 2012; 54(6):489-96. PubMed ID: 22997734 [TBL] [Abstract][Full Text] [Related]
35. [Cytoflavin® effect on endothelium function and cerebral hemodynamics in patients with hypertensive enceplalopathy]. Belova LA; Mashin VV; Kolotik-Kameneva OY; Proshin AN Antibiot Khimioter; 2014; 59(7-8):30-6. PubMed ID: 25975105 [TBL] [Abstract][Full Text] [Related]
36. [The study of the effectiveness of drug prevention mechanisms of cardiovascular aging by cytoflavin]. Kartashova EA; Romantsov MG; Sarvilina IV Adv Gerontol; 2014; 27(4):737-45. PubMed ID: 25946853 [TBL] [Abstract][Full Text] [Related]
37. [Correction of protein-lipid composition in liver mitochondria during experimental widespread purulent peritonitis]. Kosinets VA; Osochuk SS; Iarotskaia NN Eksp Klin Farmakol; 2012; 75(3):31-4. PubMed ID: 22679751 [TBL] [Abstract][Full Text] [Related]
38. [Using cytoflavin for prophylaxis and treatment of cognitive amnestic disorders in patients with heavy toxicohypoxic damage of brain]. Batotsyrenova KhV; Livanov GA; Shestova GV; Sizova KV; Velikova VD Eksp Klin Farmakol; 2012; 75(9):28-31. PubMed ID: 23156085 [TBL] [Abstract][Full Text] [Related]
40. [Efficacy of cytoflavin in therapy of encephalophathy in patients with neuroinfection]. Isakov VA; Kovalenko AL; Turkin VV; Makarov VI Antibiot Khimioter; 2010; 55(1-2):36-41. PubMed ID: 20583556 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]